JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (10): 7-13.doi: 10.6040/j.issn.1671-7554.0.2017.319
Previous Articles Next Articles
DU Yifeng, JING Ran
CLC Number:
[1] Thies B, Truschke E, Morrison-Bogorad M. Consensus report of the Working Group on molecular and biochemical markers of Alzheimers disease[J]. Neurobiol Aging, 1999, 20(2): 247. [2] Blennow K, Hampel H, Weiner M. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease[J]. Nat Rev Neurol, 2010, 6(3): 131-144. [3] Hansson O, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimers disease in patients with mild cognitive impairment: a follow-up study[J]. Lancet Neurol, 2006, 5(3): 228-234. [4] Blennow K. CSF markers for incipient Alzheimers disease[J]. Lancet Neurol, 2003, 2(10): 605-613. [5] Mattsson N, Zetterberg H, Hansson O, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment[J]. JAMA, 2009, 302(4): 385-393. [6] Fagan AM, Head D, Shah AR, et al. Decreased cerebrospinal fluid Abeta(42)correlates with brain atrophy in cognitively normal elderly[J]. Ann Neurol, 2009, 65(2): 176-183. [7] Buchhave P, Minthon L, Zetterberg H, et al. Cerebrospinal fluid levels of β-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia[J]. Arch Gen Psychiatry, 2012, 69(1): 98-106. [8] Zetterberg H, Wilson D, Andreasson U, et al. Plasma tau levels in Alzheimers disease[J]. Alzheimers Res Ther, 2013, 5(2): 9. [9] van Oijen M, Hofman A, Soares HD, et al. Plasma Abeta(1-40)and Abeta(1-42)and the risk of dementia: a prospective case-cohort study[J]. Lancet Neurol, 2006, 5(8): 655-660. [10] Evin G, Barakat A. BACE: Therapeutic target and potential biomarker for Alzheimers disease[J]. Int J Biochem Cell Biol, 2010, 42(12): 1923-1926. [11] Doody RS, Stevens JC, Beck C, et al. Practice parameter: management of dementia(an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001, 56(9): 1154-1166. [12] Jack CR, Petersen RC, Xu YC, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment[J]. Neurology, 1999, 52(7): 1397-1403. [13] Anchisi D, Borroni B, Franceschi M, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease[J].Arch Neurol, 2005, 62(11): 1728-1733. [14] Devanand DP, VanHeertum RL, Kegeles LS, et al.(99m)Tc hexamethyl-propylene-aminoxime single-photon emission computed tomography prediction of conversion from mild cognitive impairment to Alzheimer disease[J].Am J Geriatr Psychiatry, 2010, 18(11): 959-972. [15] Herholz K. Clinical amyloid imaging in Alzheimers disease[J]. Lancet Neurol, 2011, 10(7): 667-670. [16] Marchant NL, Reed BR, DeCarli CS, et al.Cerebrovascular disease, β-amyloid, and cognition in aging[J].Neurobiol Aging, 2012, 33(5): 1006.e25-36. [17] Villemagne VL, Doré V, Bourgeat P, et al. Aβ-amyloid and tau imaging in dementia[J]. Semin Nucl Med, 2017, 47(1): 75-88. [18] Dronse J, Fliessbach K, Bischof GN, et al. In vivo patterns of tau pathology, amyloid-β burden, and neuronal dysfunction in clinical variants of Alzheimers disease[J].J Alzheimers Dis, 2017, 55(2): 465-471. [19] Kumar-Singh S, Theuns J, VanBroeck B, et al. Mean age-of-onset of familial alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40[J]. Hum Mutat, 2006, 27(7): 686-695. [20] Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium[J]. JAMA, 1997, 278(16): 1349-1356. [21] Tsolaki AC, Kosmidou V, KompatsiarisI Y, et al. Brain source localization of MMN and P300 ERPs in mild cognitive impairment and Alzheimers disease: a high-density EEG approach[J]. Neurobiol Aging, 2017, 55: 190-201.doi: 10.1016/j.neurobiolaging.2017.03.025. [22] Shi M, Caudle WM. Biomarker discovery in neurodegenerative diseases: a proteomic approach[J]. Neurobiol Dis, 2009, 35(2): 157-164. [23] Wong MW, Braidy N, Poljak A, et al. Dysregulation of lipids in Alzheimers disease and their role as potential biomarkers[J]. Alzheimers Dement, 2017, 13(7): 810-827. [24] Shi M, Sui YT, Peskind ER, et al. Salivary tau species are potential biomarkers of Alzheimers disease[J]. J Alzheimers Dis, 2011, 27(2): 299-305. [25] Zhang J, Zhang CH, Li RJ, et al. Accuracy of urinary AD7c-NTP for diagnosing Alzheimers disease: a systematic review and meta-analysis[J]. J Alzheimers Dis, 2014, 40(1): 153-159. [26] Peng Q, Bakulski KM, Nan B. Cadmium and Alzheimers disease mortality in US adults: updated evidence with a urinary biomarker and extended follow-up time[J].Environ Res, 2017, 157: 44-51. doi: 10.1016/j.envres.2017.05.011. [27] Mitchell AJ, Beaumont H, Ferguson D, et al. Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: meta-analysis[J].Acta Psychiatr Scand, 2014, 130(6): 439-451. [28] Armstrong R. Oculo-visual changes and clinical considerations affecting older patients with dementia[J].Ophthalmic Physiol Opt, 2015, 35(4): 352-376. [29] Wu N, RaoX, Gao Y, et al. Amyloid-β deposition and olfactory dysfunction in an Alzheimers disease model[J].J Alzheimers Dis, 2013, 37(4): 699-712. [30] Demnitz N, Zsoldos E, Mahmood A, et al. Associations between mobility, cognition, and brain structure in healthy older adults[J]. Front Aging Neurosci, 2017, 9: 155.doi: 10.3389/fnagi.2017.00155 [31] Hugo J. Dementia and cognitive impairment: epidemiology, diagnosis, and treatment[J]. Clin Geriatr Med, 2014, 30(3): 421-442. [32] Khachaturian ZS. Revised criteria for diagnosis of Alzheimers disease: National Institute on Aging-Alzheimers Association diagnostic guidelines for Alzheimers disease[J]. Alzheimers Dement, 2011, 7(3): 253-256. [33] Dubois B, Feldman HH, Jacova C, et al. Advancing research diagnostic criteria for Alzheimers disease: the IWG-2 criteria[J]. Lancet Neurol, 2014, 13(6): 614-629. [34] Schneider LS, Tariot PN, Dagerman KS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimers disease[J]. N Engl J Med, 2006, 355(15): 1525-1538. [35] Abbott A. Failed Alzheimers trial does not kill leading theory of disease[J]. Nature, 2016, 540(7631): 15-16. [36] Vaillancourt DE. Aducanumab reduces Aβ plaques in Alzheimers disease[J]. Mov Disord, 2016, 31(11): 1631. [37] Ghosh AK, Osswald HL. BACE1(β-secretase)inhibitors for the treatment of Alzheimers disease[J]. Chem Soc Rev, 2014, 43(19): 6765-6813. [38] Claxton A, Baker LD, Hanson A, et al. Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimers disease dementia[J]. J Alzheimers Dis, 2015, 45(4):1269-1270. [39] Hardenacke K, Hashemiyoon R, Visser-Vandewalle V, et al. Deep brain stimulation of the nucleus basalis of meynert in Alzheimers dementia: potential predictors of cognitive change and results of a long-term follow-up in eight patients[J]. Brain Stimul, 2016, 9(5): 799-800. [40] Spector A, Thorgrimsen L, Woods B, et al. Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial[J]. Br J Psychiatry, 2003, 183: 248-254. [41] Kivipelto M, Solomon A, Ahtiluoto S, et al. The finnish geriatric intervention study to prevent cognitive impairment and disability(FINGER): study design and progress [J]. Alzheimers Dement, 2013, 9(6): 657-665. |
[1] | LV Yan-Feng, DING Ke, WANG Jian-Xin, YU Hua-Long, BEI Shao-Sheng. Canceration of chronic anal fistula [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 55-57. |
[2] | LI Bo-Bo, LI Dao-Tang, LIU Shu-Guang, WANG Xing-Wu. Expression of serum DKK-1 in esophageal cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 58-61. |
[3] | XU Ping, YU Guo-Fang, LI Xia. Differential diagnosis of Graves′ disease and Hashimoto′s thyroiditis by different types peak systolic velocity of the superior thyroid artery [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 62-64. |
[4] | WANG Xin, XING Chun-Yan, YANG Yan-Ping. Serum phosphopyruvate hydratase in diagnosis of invasive Candida albicans infection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 92-94. |
[5] | Yilong YIN,Xiaoming XI,Xianjing MENG. Intelligent diagnosis methods of Alzheimer's disease [J]. Journal of Shandong University (Health Sciences), 2020, 1(8): 14-21. |
[6] | FENG Zhiyu, YANG Yanliang, GUO Rui, XU Huihui, ZHANG Jian, GUO Kai, WANG Guangzhen, WANG Hui. Diagnosis and surgical treatment of pulmonary artery sling complicated with tracheal stenosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 48-51. |
[7] | GAO Jianbu, YANG Shouzhong, LI Yudong, QIAO Chong, ZHANG Songyu. Trend survey of inpatient use of drugs for acute myocardial infarction during 10 years in a hospital of Nanyang City [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(5): 66-69. |
[8] | JIN Faguang. Expatiation of the diagnosis and treatment of benign central airway stenosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 7-13. |
[9] | LU Ye, CUI Huifang, CHEN Xujun, HUANG Yihua, WU Yiqun, HUANG Jianlong, CHEN Huimin, XIONG Xianjun, CHEN Minghong. Application progress of freezing technology in intervention treatment of respiratory disease and preventive treatment for the correlated complications [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 19-22. |
[10] | SUN Fei, LI Shuxiang, WANG Lin, ZHANG Li, XIAO Shuiqing. Correlation between porphyromonas gingivalis FimA genotype V and ginival inflammatory in the orthodontic patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 59-63. |
[11] | HUO Bin, WANG Lei, WANG Haitao, HUO Xiaodong, CAO Qiang, WANG Lili, ZANG Li, WANG Jinhuan, ZHENG Guanjun, CHAI Shude. Feasibility of radioactive seed implantation in the treatment of lung cancer assisted by template combined with rib drilling technique [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(2): 26-31. |
[12] | PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46. |
[13] | WANG Tianyin, SUN Peng, WU Tong, ZHANG Dong. Application of copper wire percutaneous insertion in the treatment of cavernous hemangioma of penis: with 10 cases [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 85-88. |
[14] | LI Yun, ZHONG Wanxia, YAO Ning, HU Shuanggang, LIU Hongmao. Effects of female age on the outcome of preimplantation genetic diagnosis and screening [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 60-62. |
[15] | FAN Fengjing, ZHANG Guangying, CAO Shujuan, DING Hongyu, LIU Dequan. Diagnostic value of virtual touch tissue quantification in the differential diagnosis of breast tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(9): 48-52. |
|